Year: 2012
Type: article
Abstract: The receptor tyrosine kinase MuSK is indispensable for nerve-muscle synapse formation and maintenance. MuSK is necessary for prepatterning of the endplate zone anlage and as a signaling receptor for agrin-mediated postsynaptic differentiation. MuSK-associated proteins such as Dok7, LRP4, and Wnt11r are involved in these early events in neuromuscular junction formation. However, the mechanisms regulating synapse stability are poorly understood. Here we examine a novel role for the extracellular matrix protein biglycan in synapse stability. Synaptic development in fetal and early postnatal biglycan null (bgn(-/o)) muscle is indistinguishable from wild-type controls. However, by 5 weeks after birth, nerve-muscle synapses in bgn(-/o) mice are abnormal as judged by the presence of perijunctional folds, increased segmentation, and focal misalignment of acetylcholinesterase and AChRs. These observations indicate that previously occupied presynaptic and postsynaptic territory has been vacated. Biglycan binds MuSK and the levels of this receptor tyrosine kinase are selectively reduced at bgn(-/o) synapses. In bgn(-/o) myotubes, the initial stages of agrin-induced MuSK phosphorylation and AChR clustering are normal, but the AChR clusters are unstable. This stability defect can be substantially rescued by the addition of purified biglycan. Together, these results indicate that biglycan is an extracellular ligand for MuSK that is important for synapse stability.
Source: Journal of Neuroscience
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Funders: U.S. Department of Health and Human Services, Muscular Dystrophy Association, National Institutes of Health, National Institute on Aging, National Institute of Mental Health, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Research Resources, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NHLBI Division of Intramural Research
Awards: G1960135424, "Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy", Training in Molecular and Cell Biology and Biochemistry, Regulation of Acetylcholinesterase Synthesis & Assembly, CENTER FOR CANCER SIGNALING NETWORKS, DECORIN AND BIGLYCAN: STRUCTURE AND FUNCTION, NERVE-MUSCLE SYNAPSE ORGANIZING MOLECULES, Biglycan as a Therapeutic for Muscular Dystrophy, Interdisciplinary Predoctoral Neuroscience Training Program in the Neuroscience Graduate Program., Pediatric Scientist Development Program
OpenAlex ID: W1982623873
